Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2006-03-08 13:09:08 UTC |
---|
Update Date | 2022-09-22 18:34:16 UTC |
---|
HMDB ID | HMDB0001894 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Aspartame |
---|
Description | Aspartame is the name for an artificial, non-carbohydrate sweetener, aspartyl-phenylalanine-1-methyl ester; i.e., the methyl ester of the dipeptide of the amino acids aspartic acid and phenylalanine. It is marketed under a number of trademark names, such as Equal, and Canderel, and is an ingredient of approximately 6,000 consumer foods and beverages sold worldwide. It is commonly used in diet soft drinks, and is often provided as a table condiment. It is also used in some brands of chewable vitamin supplements. In the European Union, it is also known under the E number (additive code) E951. Aspartame is also one of the sugar substitutes used by diabetics. Upon ingestion, aspartame breaks down into several constituent chemicals, including the naturally-occurring essential amino acid phenylalanine which is a health hazard to the few people born with phenylketonuria, a congenital inability to process phenylalanine. Aspartic acid is an amino acid commonly found in foods. Approximately 40% of aspartame (by mass) is broken down into aspartic acid. Because aspartame is metabolized and absorbed very quickly (unlike aspartic acid-containing proteins in foods), it is known that aspartame could spike blood plasma levels of aspartate. Aspartic acid is in a class of chemicals known as excitotoxins. Abnormally high levels of excitotoxins have been shown in hundreds of animals studies to cause damage to areas of the brain unprotected by the blood-brain barrier and a variety of chronic diseases arising out of this neurotoxicity. |
---|
Structure | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O InChI=1S/C14H18N2O5/c1-21-14(20)11(7-9-5-3-2-4-6-9)16-13(19)10(15)8-12(17)18/h2-6,10-11H,7-8,15H2,1H3,(H,16,19)(H,17,18)/t10-,11-/m0/s1 |
---|
Synonyms | Value | Source |
---|
1-Methyl N-L-alpha-aspartyl-L-phenylalanate | ChEBI | 3-Amino-N-(alpha-carboxyphenethyl)succinamic acid N-methyl ester | ChEBI | 3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamic acid | ChEBI | AminoSweet | ChEBI | Asp-phe-ome | ChEBI | Aspartam | ChEBI | Aspartamo | ChEBI | Aspartamum | ChEBI | Aspartylphenylalanine methyl ester | ChEBI | e 951 | ChEBI | L-Aspartyl-L-phenylalanine methyl ester | ChEBI | NutraSweet | ChEBI | Sanecta | ChEBI | 1-Methyl N-L-a-aspartyl-L-phenylalanate | Generator | 1-Methyl N-L-a-aspartyl-L-phenylalanic acid | Generator | 1-Methyl N-L-alpha-aspartyl-L-phenylalanic acid | Generator | 1-Methyl N-L-α-aspartyl-L-phenylalanate | Generator | 1-Methyl N-L-α-aspartyl-L-phenylalanic acid | Generator | 3-Amino-N-(a-carboxyphenethyl)succinamate N-methyl ester | Generator | 3-Amino-N-(a-carboxyphenethyl)succinamic acid N-methyl ester | Generator | 3-Amino-N-(alpha-carboxyphenethyl)succinamate N-methyl ester | Generator | 3-Amino-N-(α-carboxyphenethyl)succinamate N-methyl ester | Generator | 3-Amino-N-(α-carboxyphenethyl)succinamic acid N-methyl ester | Generator | 3-Amino-N-(a-methoxycarbonylphenethyl) succinamate | Generator | 3-Amino-N-(a-methoxycarbonylphenethyl) succinamic acid | Generator | 3-Amino-N-(alpha-methoxycarbonylphenethyl) succinamate | Generator | 3-Amino-N-(α-methoxycarbonylphenethyl) succinamate | Generator | 3-Amino-N-(α-methoxycarbonylphenethyl) succinamic acid | Generator | Canderel | HMDB | Dipeptide sweetener | HMDB | L-Aspartyl-L-3-phenylalanine methyl ester | HMDB | L-Aspartyl-L-phenylalanyl methyl ester | HMDB | Methyl aspartylphenylalanate | HMDB | Pal sweet | HMDB | Palsweet diet | HMDB | Sweet dipeptide | HMDB | Methyl aspartylphenylalanine | HMDB | Methyl ester, aspartylphenylalanine | HMDB | Muro brand OF aspartame | HMDB | Aspartame hermes brand | HMDB | Aspartame prodes brand | HMDB | Aspartylphenylalanine, methyl | HMDB | Goldswite | HMDB | Hermesetas gold | HMDB | Aspartame fuca brand | HMDB | Aspartame muro brand | HMDB | Diététiques et santé brand OF aspartame | HMDB | Fuca brand OF aspartame | HMDB | Prodes brand OF aspartame | HMDB | Tri sweet | HMDB | Gold, hermesetas | HMDB | Hermes brand OF aspartame | HMDB | Milisucre | HMDB | Nozucar | HMDB | Tri-sweet | HMDB | TriSweet | HMDB |
|
---|
Chemical Formula | C14H18N2O5 |
---|
Average Molecular Weight | 294.3031 |
---|
Monoisotopic Molecular Weight | 294.121571696 |
---|
IUPAC Name | (3S)-3-amino-3-{[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]carbamoyl}propanoic acid |
---|
Traditional Name | aspartame |
---|
CAS Registry Number | 22839-47-0 |
---|
SMILES | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O |
---|
InChI Identifier | InChI=1S/C14H18N2O5/c1-21-14(20)11(7-9-5-3-2-4-6-9)16-13(19)10(15)8-12(17)18/h2-6,10-11H,7-8,15H2,1H3,(H,16,19)(H,17,18)/t10-,11-/m0/s1 |
---|
InChI Key | IAOZJIPTCAWIRG-QWRGUYRKSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as peptides. Peptides are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Peptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha peptide
- Phenylalanine or derivatives
- Alpha-amino acid ester
- N-acyl-alpha amino acid or derivatives
- Beta amino acid or derivatives
- Alpha-amino acid or derivatives
- Amphetamine or derivatives
- Fatty acid ester
- Monocyclic benzene moiety
- Fatty acyl
- Benzenoid
- Dicarboxylic acid or derivatives
- Methyl ester
- Amino acid or derivatives
- Amino acid
- Carboxylic acid ester
- Organic 1,3-dipolar compound
- Carboximidic acid
- Carboximidic acid derivative
- Propargyl-type 1,3-dipolar organic compound
- Carboxylic acid
- Organopnictogen compound
- Amine
- Organic oxygen compound
- Carbonyl group
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Primary amine
- Organooxygen compound
- Primary aliphatic amine
- Organonitrogen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 246.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Aspartame,1TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(=O)O[Si](C)(C)C | 2367.6 | Semi standard non polar | 33892256 | Aspartame,1TMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N[Si](C)(C)C | 2399.7 | Semi standard non polar | 33892256 | Aspartame,1TMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N)CC(=O)O)[Si](C)(C)C | 2369.4 | Semi standard non polar | 33892256 | Aspartame,2TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C)N[Si](C)(C)C | 2408.4 | Semi standard non polar | 33892256 | Aspartame,2TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C)N[Si](C)(C)C | 2426.9 | Standard non polar | 33892256 | Aspartame,2TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C)N[Si](C)(C)C | 3352.8 | Standard polar | 33892256 | Aspartame,2TMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N)CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 2349.3 | Semi standard non polar | 33892256 | Aspartame,2TMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N)CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 2398.6 | Standard non polar | 33892256 | Aspartame,2TMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N)CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 3582.2 | Standard polar | 33892256 | Aspartame,2TMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N[Si](C)(C)C)[Si](C)(C)C | 2407.4 | Semi standard non polar | 33892256 | Aspartame,2TMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N[Si](C)(C)C)[Si](C)(C)C | 2440.4 | Standard non polar | 33892256 | Aspartame,2TMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N[Si](C)(C)C)[Si](C)(C)C | 3327.9 | Standard polar | 33892256 | Aspartame,2TMS,isomer #4 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2525.7 | Semi standard non polar | 33892256 | Aspartame,2TMS,isomer #4 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 2496.4 | Standard non polar | 33892256 | Aspartame,2TMS,isomer #4 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 3426.6 | Standard polar | 33892256 | Aspartame,3TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C)N[Si](C)(C)C)[Si](C)(C)C | 2404.9 | Semi standard non polar | 33892256 | Aspartame,3TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C)N[Si](C)(C)C)[Si](C)(C)C | 2476.5 | Standard non polar | 33892256 | Aspartame,3TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C)N[Si](C)(C)C)[Si](C)(C)C | 3053.8 | Standard polar | 33892256 | Aspartame,3TMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2511.9 | Semi standard non polar | 33892256 | Aspartame,3TMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 2543.9 | Standard non polar | 33892256 | Aspartame,3TMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 3135.9 | Standard polar | 33892256 | Aspartame,3TMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2522.0 | Semi standard non polar | 33892256 | Aspartame,3TMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2559.3 | Standard non polar | 33892256 | Aspartame,3TMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 3134.0 | Standard polar | 33892256 | Aspartame,4TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2559.2 | Semi standard non polar | 33892256 | Aspartame,4TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2596.1 | Standard non polar | 33892256 | Aspartame,4TMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2922.5 | Standard polar | 33892256 | Aspartame,1TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(=O)O[Si](C)(C)C(C)(C)C | 2602.3 | Semi standard non polar | 33892256 | Aspartame,1TBDMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N[Si](C)(C)C(C)(C)C | 2599.7 | Semi standard non polar | 33892256 | Aspartame,1TBDMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N)CC(=O)O)[Si](C)(C)C(C)(C)C | 2604.9 | Semi standard non polar | 33892256 | Aspartame,2TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 2829.7 | Semi standard non polar | 33892256 | Aspartame,2TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 2797.5 | Standard non polar | 33892256 | Aspartame,2TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C | 3447.6 | Standard polar | 33892256 | Aspartame,2TBDMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N)CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2841.4 | Semi standard non polar | 33892256 | Aspartame,2TBDMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N)CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2799.1 | Standard non polar | 33892256 | Aspartame,2TBDMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@@H](N)CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3633.5 | Standard polar | 33892256 | Aspartame,2TBDMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2860.6 | Semi standard non polar | 33892256 | Aspartame,2TBDMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2787.6 | Standard non polar | 33892256 | Aspartame,2TBDMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3426.5 | Standard polar | 33892256 | Aspartame,2TBDMS,isomer #4 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2983.3 | Semi standard non polar | 33892256 | Aspartame,2TBDMS,isomer #4 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2834.7 | Standard non polar | 33892256 | Aspartame,2TBDMS,isomer #4 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3461.8 | Standard polar | 33892256 | Aspartame,3TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3060.9 | Semi standard non polar | 33892256 | Aspartame,3TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3007.3 | Standard non polar | 33892256 | Aspartame,3TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3317.1 | Standard polar | 33892256 | Aspartame,3TBDMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3211.9 | Semi standard non polar | 33892256 | Aspartame,3TBDMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3063.2 | Standard non polar | 33892256 | Aspartame,3TBDMS,isomer #2 | COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3332.3 | Standard polar | 33892256 | Aspartame,3TBDMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3215.2 | Semi standard non polar | 33892256 | Aspartame,3TBDMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3060.7 | Standard non polar | 33892256 | Aspartame,3TBDMS,isomer #3 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3332.5 | Standard polar | 33892256 | Aspartame,4TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3428.2 | Semi standard non polar | 33892256 | Aspartame,4TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3268.1 | Standard non polar | 33892256 | Aspartame,4TBDMS,isomer #1 | COC(=O)[C@H](CC1=CC=CC=C1)N(C(=O)[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3237.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Aspartame GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-9220000000-2625126bd17025b83933 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aspartame GC-MS (1 TMS) - 70eV, Positive | splash10-03di-5904000000-075be5fd36b94f425650 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Aspartame GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-00ns-0690000000-e92f66ca1ae82b0ccd81 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-00di-2900000000-8eec324eec1e64466b1c | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-01b9-2900000000-e8415697953bc139924b | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame LC-ESI-qTof , Positive-QTOF | splash10-0080-0890000000-b2e2c2a89ceaf3d1f9db | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame LC-ESI-QTOF , positive-QTOF | splash10-00e9-0930000000-d8dbb5a34c019dc70708 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame , positive-QTOF | splash10-0080-0890000000-b2e2c2a89ceaf3d1f9db | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 40V, Negative-QTOF | splash10-0007-9300000000-752aa89264f270a0fa05 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 20V, Negative-QTOF | splash10-0uka-6970000000-013c7cbdca3d99b6f9fd | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame -1V, Positive-QTOF | splash10-00e9-0930000000-d8dbb5a34c019dc70708 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 40V, Positive-QTOF | splash10-00di-4900000000-44d957a1f7597badb988 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 10V, Negative-QTOF | splash10-0j4i-0290000000-13341a263598276b7250 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 10V, Positive-QTOF | splash10-001r-0590000000-892944c774f24420614a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 20V, Positive-QTOF | splash10-00di-1910000000-d608ab28a66f1df0e8ca | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 20V, Negative-QTOF | splash10-0fdn-7960000000-f6a714d56477fcabf6fa | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 30V, Negative-QTOF | splash10-00r7-9510000000-4252f225428cba6bb01b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 10V, Negative-QTOF | splash10-0j4i-0290000000-08042f6313a2bfffda83 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Aspartame 40V, Negative-QTOF | splash10-00kg-9400000000-a62cb6f22dc5c7b0f1d4 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aspartame 10V, Positive-QTOF | splash10-004j-4390000000-5ea0d55c8c75f40eefde | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aspartame 20V, Positive-QTOF | splash10-0109-9730000000-badb4105789050b52346 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aspartame 40V, Positive-QTOF | splash10-0006-9100000000-22c71b3445a360c7886a | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aspartame 10V, Negative-QTOF | splash10-0006-0290000000-c48af459412db76084cc | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aspartame 20V, Negative-QTOF | splash10-02bg-1690000000-df82228a7343c200b8d4 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aspartame 40V, Negative-QTOF | splash10-03gu-9700000000-db183663829759af70f9 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aspartame 10V, Negative-QTOF | splash10-0006-0090000000-c13994947a4a009ec6b8 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Aspartame 20V, Negative-QTOF | splash10-004j-3960000000-685d025546bdd8eba5c0 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
General References | - Lam S: Stereoselective analysis of D and L dansyl amino acids as the mixed chelate copper(II) complexes by HPLC. J Chromatogr Sci. 1984 Sep;22(9):416-23. [PubMed:6490790 ]
- Lam S, Azumaya H, Karmen A: High-performance liquid chromatography of amino acids in urine and cerebrospinal fluid. J Chromatogr. 1984 Oct 19;302:21-9. [PubMed:6501504 ]
- Fernstrom JD: Dietary amino acids and brain function. J Am Diet Assoc. 1994 Jan;94(1):71-7. [PubMed:7903674 ]
- Azcurra AI, Calamari SE, Yankilevich ER, Battellino LJ, Cattoni ST, Colantonio G: [Effects of local treatment with sodium fluoride mouthrinse on peroxidase and hypothiocyanite saliva levels in adolescent]/. Acta Physiol Pharmacol Ther Latinoam. 1997;47(4):211-20. [PubMed:9504181 ]
- Busch U, Schmid J, Heinzel G, Schmaus H, Baierl J, Huber C, Roth W: Pharmacokinetics of meloxicam in animals and the relevance to humans. Drug Metab Dispos. 1998 Jun;26(6):576-84. [PubMed:9616195 ]
- Bidiwala KS, Lorenz JM, Kleinman LI: Renal function correlates of postnatal diuresis in preterm infants. Pediatrics. 1988 Jul;82(1):50-8. [PubMed:3288958 ]
- Burns TS, Stargel WW, Tschanz C, Kotsonis FN, Hurwitz A: Aspartame and sucrose produce a similar increase in the plasma phenylalanine to large neutral amino acid ratio in healthy subjects. Pharmacology. 1991;43(4):210-9. [PubMed:1771173 ]
- Romano M, Casacci F, De Marchi F, Pacei T, Esteve A, Lomuscio G, Mennini T, Salmona M: Effects of aspartame and carbohydrate administration on human and rat plasma large neutral amino acid levels and rat brain amino acid and monoamine levels. J Nutr. 1989 Jan;119(1):75-81. [PubMed:2913236 ]
- McMasters DR, Vedani A: Ochratoxin binding to phenylalanyl-tRNA synthetase: computational approach to the mechanism of ochratoxicosis and its antagonism. J Med Chem. 1999 Aug 12;42(16):3075-86. [PubMed:10447951 ]
- Kochansky CJ, Rippley RK, Yan KX, Song H, Wallace MA, Dean D, Jones AN, Lasseter K, Schwartz J, Vincent SH, Franklin RB, Wagner J: Absorption, metabolism, and excretion of [14C]MK-0767 (2-methoxy-5-(2,4-dioxo-5-thiazolidinyl)-N-[[4-(trifluoromethyl)phenyl] methyl]benzamide) in humans. Drug Metab Dispos. 2006 Sep;34(9):1457-61. Epub 2006 Jun 13. [PubMed:16772365 ]
- Koeppe RA, Shulkin BL, Rosenspire KC, Shaw LA, Betz AL, Mangner T, Price JC, Agranoff BW: Effect of aspartame-derived phenylalanine on neutral amino acid uptake in human brain: a positron emission tomography study. J Neurochem. 1991 May;56(5):1526-35. [PubMed:2013754 ]
- Yang D, Beylot M, Agarwal KC, Soloviev MV, Brunengraber H: Assay of the human liver citric acid cycle probe phenylacetylglutamine and of phenylacetate in plasma by gas chromatography-mass spectrometry. Anal Biochem. 1993 Jul;212(1):277-82. [PubMed:8368503 ]
- Maher TJ, Wurtman RJ: Possible neurologic effects of aspartame, a widely used food additive. Environ Health Perspect. 1987 Nov;75:53-7. [PubMed:3319565 ]
- Wurtman RJ, Maher TJ: Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. Short note. J Neural Transm. 1987;70(1-2):169-73. [PubMed:3668518 ]
|
---|